Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Peginterferon alfa-2a Approval Information - Licensing Action

Proper name: Peginterferon alfa-2a
Tradename: PEGASYS
Manufacturer: Hoffman-La Roche, Inc, Nutley, NJ, License #0136
Indication for Use: Combination therapy with Ribavirin, USP (Copegus), for the treatment of chronic hepatitis C virus infection
Approval Date: 12/3/2002
Type of submission: Biologics license application supplement

 

Label (PDF)

-
-